Alvesco and Proventil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alvesco (ciclesonide) and Proventil (albuterol). Common drug interactions include musculoskeletal stiffness among females and aphasia among males.

The phase IV clinical study analyzes what interactions people have when they take Alvesco and Proventil. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Alvesco?

Alvesco has active ingredients of ciclesonide. It is often used in asthma. eHealthMe is studying from 13,134 Alvesco users. Check the latest studies of Alvesco.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.



On Jul, 20, 2026

58 people who take Alvesco and Proventil together, and have interactions are studied.

Alvesco and Proventil drug interactions.

What are the common drug interactions of Alvesco and Proventil, by gender? *:

female:

  1. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  2. Myalgia (muscle pain)
  3. Nephropathy (damage to or disease of a kidney)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Ocular hyperaemia (an abnormally large amount of blood in eye)
  6. Pain in extremity
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Peripheral swelling
  9. Photophobia (extreme sensitivity to light)
  10. Pneumonia

male:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Confusional state
  3. Infusion related reaction
  4. Pneumonia
  5. Decreased appetite
  6. Dyspnoea (difficult or laboured respiration)
  7. Heart rate increased
  8. Restlessness (not able to rest)
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  10. Chest discomfort

What are the common drug interactions of Alvesco and Proventil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Headache (pain in head)

10-19:

  1. Decreased appetite
  2. Dyspnoea (difficult or laboured respiration)
  3. Heart rate increased
  4. Restlessness (not able to rest)

20-29:

n/a

30-39:

  1. Gestational diabetes (diabetes in pregnancy)

40-49:

  1. Anticholinergic syndrome (absolute or relative reduction in cholinergic activity in the central nervous system)
  2. Fatigue (feeling of tiredness)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Micturition frequency decreased (less frequency of urinate)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Peripheral swelling
  7. Sedation
  8. Slow response to stimuli (slow response by nerves)
  9. Therapeutic response unexpected

50-59:

  1. Headache (pain in head)
  2. Hypersensitivity
  3. Anaphylactic reaction (serious allergic reaction)
  4. Anxiety
  5. Blood pressure increased
  6. Dyspnoea (difficult or laboured respiration)
  7. Flushing (the warm, red condition of human skin)
  8. Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Sensation of foreign body

60+:

  1. Confusional state
  2. Dizziness
  3. Application site dryness
  4. Application site erythema (redness of the skin at application site)
  5. Application site irritation
  6. Application site pruritus (application site severe itching of the skin)
  7. Back pain
  8. Blood sodium decreased
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 9 people, 15.52%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 13.79%
  3. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 8.62%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 8.62%
  5. Bone Marrow Conditioning Regimen: 5 people, 8.62%
  6. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 5.17%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.17%
  8. Hypersensitivity: 3 people, 5.17%
  9. High Blood Pressure: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Alvesco and Proventil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alvesco and Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alvesco:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alvesco and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide and albuterol (the active ingredients of Alvesco and Proventil, respectively), and Alvesco and Proventil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: